top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
What is Kava?
Unlike most substances reviewed at Drug Science, kava is not simply a drug, but inclusive of wider cultural understandings.
Dr Apo Aporosa
Jun 24, 20246 min read
Doubt it not, MDMA is a medicine
The AdCom was asked to make a binary yes-no vote on both the efficacy and benefit-risk of MDMA, with scores of 9-2 and 10-1 against for each
Prof David Nutt and Prof Jo Neill
Jun 21, 20246 min read
Report of the Dutch State Committee on MDMA: A summary of findings and recommendations
On June 6, 2024, the Dutch State Committee MDMA presented its report entitled “MDMA: Beyond ecstasy” to the Dutch Minister of Medical Care.
Wim van den Brink
Jun 19, 20244 min read
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
There are important differences between individuals aged 65+ years and younger individuals receiving cannabis-based medicinal products. Olde
Michael Lynskey
Jun 18, 20242 min read
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
Chronic pain is one of the most common conditions for which people seek treatment with cannabis-based medicinal products (CBMPs) and there i
Alkyoni Anthanasiou-Fragkouli
Jun 6, 20242 min read
How can we prepare psychiatry for a psychedelic future?
The Therapeutic Goods Administration (TGA) in Australia recently made a groundbreaking decision to reschedule two drugs as treatments for ce
Drug Science
May 23, 20243 min read
In defence of the decriminalisation of drug possession in the UK
Authors Alex Stevens, Niamh Eastwood and Kirstie Douse Published March 24, 2024 Abstract In this review article, we develop the case for...
Alex Stevens, Niamh Eastwood and more
Mar 24, 20241 min read
Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
Authors Ksenia Cassidy, CJ Healy, Eva Henje and Wendy D’Andrea Published March 20, 2024 Abstract Challenging experiences in ayahuasca...
Ksenia Cassidy, Eva Henje and more
Mar 20, 20241 min read
Psilocybin shows promise in supporting symptoms of Premenstrual Dysphoric Disorder
Pioneering research highlights the potential for treating the symptoms of Premenstrual Dysphoric Disorder (PMDD). Written by Eleanor...
Eleanor Taylor
Mar 18, 20247 min read
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Authors Michael Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Schlag and David Nutt Published March 12, 2024 Background...
Dr Anne Schlag, Professor David Nutt and more
Mar 12, 20241 min read
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study
Authors Simon GD Ruffell, Sam Gandy, WaiFung Tsang, Rono Lopez, Nathan O’Rourke, Arsalan Akhtar, Nige Netzband, Jack Hollingdale, Daniel...
Simon Ruffell, Sam Gandy, and more
Feb 28, 20242 min read
A history of the European Medical Society for Psycholytic Therapy (EPT) 1964–1974
Authors Torsten Passie Published February 22, 2024 Abstract The emergence of a so-called psychedelic renaissance has been proposed to...
Torsten Passie
Feb 22, 20241 min read
Will the war on vaping result in more harm?
Key take-home messages: The disposable vape ban is intended to curb youth vaping, addressing the increasing use of vaping among youth in...
Drug Science
Feb 6, 20245 min read
Teaching Children about Vaping
Teaching Children about Vaping. In 2023, over 20% of children in the UK had tried vaping, up from less than 11.2% in 2021.
Hannah Dawes
Feb 5, 20243 min read
Investigation of the household storage of medicines and disposal practices in Parklands sub-county in Nairobi, Kenya
Over time there has been an increase in access to medicine, leading to the bulk of drugs becoming unused and being kept at home.
Shreya Malde and Naumih Noah
Jan 31, 20242 min read
The end of the pilot stage: The long and winding road to drug checking in the UK
All images used in this blog are owned by The Loop Written by – Professor Fiona Measham Founder and Chair of The Loop Chair in...
Professor Fiona Measham
Jan 26, 20247 min read
Overdose Prevention Centres, Safe Consumption Sites, and Drug Consumption Rooms: A Rapid Evidence Review
By Dr Gillian W Shorter Drug Science is pleased to announce the release of a rapid evidence review collating and synthesizing the...
Dr Gillian Shorter
Jan 10, 20242 min read
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Minorities’ diminished psychedelic returns: Cardio-metabolic health. Race differences remain a critically understudied gap in psychedelic li
Sean Matthew Viña
Jan 9, 20241 min read
Results from Long COVID trial published
We are delighted to share the news that the results from the Long COVID trial have been published by the British Journal of Clinical Pharmac
Drug Science
Jan 7, 20242 min read
How Much Do You Know About Medical Cannabis?
In November we brought over 200 patients together in London (and many more online) for the second UK Patient Conference, hosted by Drug Scie
Sarah Sinclair
Jan 4, 20243 min read
Was ketamine the cause of Matthew Perry’s death?
The death of Matthew Perry from a combination of ketamine and drowning is a sad loss of an exceptional talent.
Professor David Nutt
Dec 19, 20232 min read
UK’s largest medical cannabis study announces new industry partners
Launched in 2019, and now over 4000 patients in, T21 is building the scientific evidence base for the safety and efficacy of Cannabis-Based
Drug Science
Dec 12, 20233 min read
Patients with a terminal diagnosis want to access psilocybin in the UK
Terminal patients are calling for compassionate access to be granted for psilocybin — the psychedelic substance found in fungi known as ‘mag
Drug Science
Dec 11, 20232 min read
Psilocybin for Existential Distress
Read our latest report on why patients experiencing 'Existential Distress'
ought to be permitted access to psilocybin-assisted psychotherap
James Bunn
Dec 11, 20235 min read
bottom of page